Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Senators Slam FDA And PTO For Patent ‘Oversight Gaps’
‘Lack Of Co-ordination’ Between Authorities Criticized By Hassan And Cassidy
Jun 01 2022
•
By
Dave Wallace
The PTO has been criticized for allowing flawed patents • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin